Overview
Non-involuting congenital hemangioma (NICH) is a rare vascular tumor that is fully formed at birth and, unlike the more common infantile hemangiomas, does not undergo spontaneous regression or involution over time. NICH belongs to the group of congenital hemangiomas, which also includes rapidly involuting congenital hemangioma (RICH) and partially involuting congenital hemangioma (PICH). These lesions are distinct from infantile hemangiomas both clinically and histologically, and they are notably GLUT1-negative on immunohistochemistry, which helps differentiate them from infantile hemangiomas. NICH typically presents as a solitary, well-circumscribed, raised or flat vascular plaque or nodule on the skin. The lesion is often pink, violaceous, or bluish in color, sometimes with a pale rim or prominent overlying telangiectasias. It can occur anywhere on the body, including the head, trunk, and extremities. Because NICH persists indefinitely without regression, it may cause cosmetic concerns, and in some cases, it can be associated with local warmth, increased blood flow, or mild coagulopathy. The lesion primarily affects the skin and subcutaneous tissues, though deeper soft tissue involvement can occasionally occur. Treatment of NICH is primarily surgical excision when the lesion causes functional impairment, cosmetic disfigurement, or complications such as pain or ulceration. Unlike infantile hemangiomas, NICH does not respond to beta-blocker therapy (such as propranolol) or corticosteroids. In cases where surgery is not feasible or desired, observation and monitoring may be appropriate, as the lesions are generally benign. Embolization may be considered in select cases with significant arteriovenous shunting. Long-term prognosis is generally favorable, as malignant transformation has not been reported.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Non-involuting congenital hemangioma.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Non-involuting congenital hemangioma at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Non-involuting congenital hemangioma.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Non-involuting congenital hemangioma.
Community
No community posts yet. Be the first to share your experience with Non-involuting congenital hemangioma.
Start the conversation →Latest news about Non-involuting congenital hemangioma
No recent news articles for Non-involuting congenital hemangioma.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Non-involuting congenital hemangioma
What is Non-involuting congenital hemangioma?
Non-involuting congenital hemangioma (NICH) is a rare vascular tumor that is fully formed at birth and, unlike the more common infantile hemangiomas, does not undergo spontaneous regression or involution over time. NICH belongs to the group of congenital hemangiomas, which also includes rapidly involuting congenital hemangioma (RICH) and partially involuting congenital hemangioma (PICH). These lesions are distinct from infantile hemangiomas both clinically and histologically, and they are notably GLUT1-negative on immunohistochemistry, which helps differentiate them from infantile hemangiomas.
How is Non-involuting congenital hemangioma inherited?
Non-involuting congenital hemangioma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Non-involuting congenital hemangioma typically begin?
Typical onset of Non-involuting congenital hemangioma is neonatal. Age of onset can vary across affected individuals.